ResMed (RMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
ResMed (RMD) PT Lifted to $57 on Solid Q1
October 24, 2014 11:23 AM EDTPiper Jaffray analyst David Clair reiterated an Overweight rating and boosted his price target on ResMed (NYSE: RMD) price target of $57.00 (from $55.00) following solid Q1 results.
Clair commented, "ResMed reported 1Q15 revenue of $380.4M, above consensus' $374.8M and our $373.3M... More
William Blair Upgrades ResMed (RMD) to Outperform
October 24, 2014 7:09 AM EDTWilliam Blair upgraded ResMed (NYSE: RMD) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $47.70 yesterday.
... MoreResMed (RMD) Declares $0.28 Quarterly Dividend; 2.3% Yield
October 23, 2014 4:21 PM EDTResMed (NYSE: RMD) declared a quarterly dividend of $0.28 per share, or $1.12 annualized.
The dividend will be payable on December 18, 2014, to stockholders of record on November 20, 2014, with an ex-dividend date of November 18, 2014.
The annual yield on the dividend is 2.3... More
